The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
p53 in ferroptosis regulation: the new weapon for the old guardian
Open accessAbstract
Although the conventional activities of p53 such as cell cycle arrest, senescence, and apoptosis are well accepted as the major checkpoints in stress responses, accumulating evidence implicates the importance of other tumor suppression mechanisms. Among these unconventional activities, an iron-dependent form of non-apoptotic cell death, termed ferroptosis, attracts great interest. Unlike apoptotic cell death, activation of p53 alone is not sufficient to induce ferroptosis directly; instead, through its metabolic targets, p53 is able to modulate the ferroptosis response in the presence of ferroptosis inducers such as GPX4 inhibitors or high levels of ROS. Here, we review the role of ferroptosis in p53-mediated tumor suppression, with a focus on what cellular factors are critical for p53-dependent ferroptosis during tumor suppression and how p53 modulates both the canonical (GPX4-dependent) and the non-canonical (GPX4-independent) ferroptosis pathways. We also discuss the possibility of targeting p53-mediated ferroptotic responses for the treatment of human cancers and potentially, other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is known that p53 modulates ferroptosis, an iron-dependent, nonapoptotic form of cell death induced by lipid peroxidation in response to high levels of ROS [ 71 ].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ma, S., Sun, L., Wu, W., Jiang-li, W., Sun, Z., & Ren, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.551318 · Cited by 202
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Self-citationFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Research works printed but not linked: 1
- Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62. · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 540
Mechanism and importance of ferroptosis in clear cell renal cell carcinoma treatment
Neeraj, M. A., Noh, S., Chae, J., & Choi, J. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.105004 · Cited by 2
Ferroptosis as a potential therapeutic target for post-traumatic stress disorder
Zhang, Q., Mao, J.-D., Chen, H., Wang, M., Wu, Y., & Wang, C. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1648047 · Cited by 2
Strategies and mechanisms of radiosensitization in cancer therapy
Xie, G., Wang, F., & Ma, X. (2025) · Biophysics Reports · doi:10.52601/bpr.2025.250056 · Cited by 2
Gambogic acid restores wild-type-like p53 functions to induce ferroptosis in mutant p53 cancer cells
Wang, J., Zhang, L., Li, R., Yang, R., Yang, F., Yu, F., & Zhang, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117533 · Cited by 2
Regulatory Effects of Oncogenes and Tumor Suppressor Genes on Tumor Immune Microenvironment
Shu-Yi, T. A. N., & Zhang, J. (2025) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/j.pibb.2025.0317 · Cited by 2
Chen, Q., Xu, C., Fei, J., Wu, Z., Wang, Y., Wang, Y., & Shao, S. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s528964 · Cited by 2
MiR-424-3p suppresses adipogenesis via HNRNPA0 targeting and p53-mediated ferroptosis
Li, M., Ye, Y., Lin, S., Jiang, H., Zhang, D., & Zhang, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159712 · Cited by 2
WWOX protects against ferroptosis to alleviate acute lung injury by mediating p53 deacetylation
Wang, C., Qing, C., Chen, W., Yao, H., Hu, Z., Zhou, C., Yang, Y., Singla, S., & Zeng, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116067 · Cited by 2
Taurino, G., Griffini, E., Toscani, D., Maccari, C., Tardito, S., Bianchi, M. G., Casati, L., Dander, E., D’Amico, G., Andreoli, R., et al. (2026) · Blood Neoplasia · doi:10.1016/j.bneo.2026.100195 · Cited by 2
Tan, X., Li, K.-F., Yuan, Y., Xia, M., Zhao, F., Ying, H., Zhou, Z., Gao, P., Xie, G., Li, X., et al. (2026) · Advanced Science · doi:10.1002/advs.202513796 · Cited by 2
Dar, M. J., Huston, R. H., Purayil, N., Cronin, A. I., Gondal, S. A., Nakhasi, H. L., Brito, R., Gannavaram, S., & Satoskar, A. R. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104071 · Cited by 2
Crossroads of iron, copper, and zinc in cancer: a paradox of toxicity and therapy
Thakur, P., & Patel, T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11821-y · Cited by 2
Wu, S.-Y., Liao, E., Wen, Y., Wang, Y., Meng, H., Chou, H., & Chan, H. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111259 · Cited by 2
Feng, B., Pei, Y., Zhang, W., Zheng, Q., & Zhou, Y. (2024) · Discover Oncology · doi:10.1007/s12672-024-01228-1 · Cited by 2
Zhou, X., Chen, Y., Kang, X., Zhao, A., & Yang, S. (2024) · Animals · doi:10.3390/ani14233516 · Cited by 2
The director of cell fate: p53 plays roles in programmed cell death
Gan, Y., & Zhou, X. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2025-0007 · Cited by 2
Yang, F., Hung, C.-H., Lo, Y.-L., Li, C., Ravula, V., & Wang, L. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106972 · Cited by 2
Identification of FADS2 as a Contributor of Ferroptosis Escape in Bladder Cancer
Li, P., Yao, S., Qi, W., Liu, H., Zhang, X., Zhou, B., Zhang, S., Zhang, Y., Liang, H., Huang, H., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70710 · Cited by 2
Guo, X., Wang, T., Xia, J., Zeng, H., & Shi, W. (2024) · PubMed Central · doi:10.3779/j.issn.1009-3419.2024.101.06 · Cited by 2
Wang, C.-D., Ma, B.-Q., & Yi, B.-S. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i12.477 · Cited by 1
Luo, S., Xu, J., Mo, C., Gong, W., Li, C., Hou, X., & Ou, M. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2024-0378 · Cited by 1
Zhang, J., Wang, X., Wang, J., Wen, X., Chen, S., Wang, T., Wang, B., & Hu, W. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114438 · Cited by 1
Gray Frequency-Based Methodology for Assessing Cell Damage
Li, A., Zhao, L., Liu, C., Xu, X., & Jia, J. (2025) · ACS Omega · doi:10.1021/acsomega.4c11226 · Cited by 1
Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia
Шевченко, В. Е., Kushnir, T., Gudkova, M. V., & Arnotskaya, N. E. (2025) · Advances in molecular oncology · doi:10.17650/2313-805x-2025-12-2-58-67 · Cited by 1
Yang, X., Wang, C., Ouyang, D., Xu, H., Wu, Z., Ye, H., & Yan, P. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70155 · Cited by 1
Zhou, X., Cheng, J., Yang, X., & Sun, D. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128360 · Cited by 1
Pensotti, R., Sciandrone, B., Bovio, F., Schröter, L., Maglioni, S., Thewes, L., Forcella, M. E., Rossi, A., Fusi, P. A., Berndt, C., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103912 · Cited by 2
Icariin Inhibits Lung Adenocarcinoma Progression Through TP53-Mediated Ferroptosis
Jin, Q., OuYang, L., Li, J., Yang, X., & Guo, L. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s539483 · Cited by 1
Distinct mechanisms of cell in breast cancer and their clinical implication
Li, A., Liu, S., Xuan, Y., Liang, Y., Wang, L., & Zhao, L. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10104-9 · Cited by 1
Li, X., Zhang, H., Yu, P., Chen, X., Yang, Y., & Xu, S. (2025) · Environment International · doi:10.1016/j.envint.2025.110032 · Cited by 1
Wang, X., Wei, Z., Zhou, S., Liu, Y., Chu, P., Xu, X., & Zhu, L. (2026) · Journal of Oceanology and Limnology · doi:10.1007/s00343-025-5130-0 · Cited by 1
Self-citationTRAF6 promotes the ferroptosis defense through AKT/mitochondria damage in KRAS-driven lung cancer
Yu, W., Cui, Y., Li, S., & Luo, L. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117746 · Cited by 1
E3 ubiquitin ligase PELI1 promotes ferroptosis in granulosa cells in PCOS by degrading Fth1
Zha, X., Liang, C. H. E. N., Tan, Z., Wu, T., Xiong, Q., Wang, H., Kuang, Y., Xing, N., Lu, A., Sun, L., et al. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.106948 · Cited by 1
Luo, S., Zhu, J., Yang, L., Liu, J., & Deng, Y. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s563534 · Cited by 1
Ubiquitin regulatory code: unraveling tumor cell ferroptosis
Liu, X., Liu, J., Chen, W., Zhang, J., wei, Y., & Sun, L. L. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105172 · Cited by 1
Lv, X., He, Z., Xue, J., Yang, Y., Tang, Y., Cai, H., Luo, H., Li, X., Dong, Z., Liu, Y., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157999 · Cited by 1
Self-citationLi, Y., Qian, T., Han, Z., Wang, C., Zhang, M. X., Huang, C., Gu, Q., Zhang, S., Lin, Y., Wang, J., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1767384 · Cited by 1
Liu, A., Xing, L., Li, J., Yao, M., Song, J., Guo, W., Duan, P., & Li, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261420211 · Cited by 1
Zeng, H., Qiu, B., Yang, J., Xie, Y., Huang, H., Zhang, S., Nie, H., Wang, N., Huang, Z., Wu, L., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00016 · Cited by 1
Ye, M., Wu, Y., Chen, Z., Zhai, Q., Li, L., Yan, Z., Li, M., Gu, C., Wen, Y., Liao, S., et al. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101411 · Cited by 2
Wang, H., Yin, L., Zheng, H., Shi, Z., & Zhao, C. (2026) · The FASEB Journal · doi:10.1096/fj.202601128r · Cited by 1
Hao, Q., Jiashu, Y. U. E., Li, P., & He, Q. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158468 · Cited by 1
Xu, C., Ke, C., Zhong, Y.-L., Yang, X.-H., Wang, M.-M., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103225 · Cited by 1
ROS as a powerful instrument for the advanced cancer prevention and management: Facts and outlook
Tang, Q., Cui, L., Du, W., Ruan, Y., Yang, L., Fu, C., Gui, J., Liu, Q., Chen, Y., Qiao, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.002 · Cited by 1
Guo, X., Zhang, Y., Li, Q., Shi, F., HuangFu, Y., Li, J., & Lao, X. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01926-1 · Cited by 1
Identify Non-mutational p53 Functional Deficiency in Human Cancers
Li, Q., Zhang, Y., Luo, S., Zhang, Z., Oberg, A. L., Kozono, D., Lu, H., Sarkaria, J. N., Ma, L., & Wang, L. (2024) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzae064 · Cited by 2
Recent Advances in the Development of Synthetic Ferroptosis Inhibitors
Klejborowska, G., Scarpellini, C., Lanthier, C., & Augustyns, K. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch14 · Cited by 1
Zou, L., Zhang, T., Yang, C., Liu, W., Fahira, A., Yang, D., Zheng, B., Yao, X., Liu, Y., & Huang, Z. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23874 · Cited by 1
Self-citationLu, Z., Yu, J., Lu, T., Deng, S., Zheng, X., Ji, B., Wu, X., & Yu, Y. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02515-2 · Cited by 1
Xiao, X., Xie, R., Zhang, Y., Yin, Y., Chen, Y., Sun, N., Cheng, Z., & Zhang, G. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167765 · Cited by 1
NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer
Zhao, S., Lin, J., Zhu, B., Jin, Y., Dong, Q., Ruan, X., Jin, D., Yi, Y., Bai, B., Li, H., et al. (2025) · eLife · doi:10.7554/elife.103904.3 · Cited by 1
Ferroptosis induction by engineered liposomes for enhanced tumor therapy
Ghasempour, A., Tokallou, M. A., Allaf, M. R. N., Moradi, M., Dehghan, H., Sedighi, M., Shahbazi, M., & Arab, F. L. (2025) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.16.97 · Cited by 1
Hu, R., Tang, K.-Y., Xiao, M., Yang, J. P., Tao, X.-X., Hu, B.-B., Xu, S., & Shu, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120687 · Cited by 1
Yu, L., Deng, G., Zhao, Z., Xin, J., Wang, H., Zhou, J., Zhang, H., Xie, G., Li, J., & Bai, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2181247/v1 · Cited by 1
Editorial: Ferroptosis in cancer and beyond
Wang, X., Chen, G., Pan, C., & Liu, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1115974 · Cited by 1
Self-citationGu, W., Pan, T., Wang, X., Kang, L., Liu, N., Piao, M., & Feng, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4306415/v1 · Cited by 1
Self-citationNOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancerPreprint
Zhao, S., Lin, J., Zhu, B., Jin, Y., Dong, Q., Ruan, X., Jin, D., Yi, Y., Bai, B., Li, H., et al. (2024) · eLife · doi:10.7554/elife.103904 · Cited by 1
図解 避難生活を生き抜く うおつか流防災食 (特集 つくる・伝える 災害にそなえる食の知恵)
魚柄, 仁. (2008) · 食農教育
Cheng, J., Xu, C., Yu, W., Xie, D., Wang, Q., Chen, B., Yang, H., Xi, Y., Yu, L., Yan, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2628608/v1
BABANEZHAD-GAJOUTI, A., & Amniattalab, A. (2023) · TURKISH JOURNAL OF VETERINARY AND ANIMAL SCIENCES · doi:10.55730/1300-0128.4308
Editorial: Ferroptosis in cancer and Beyond—volume II
Wang, X., Lu, J., Chen, G., Pan, C., & Liu, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1265127
Self-citationXiao, H.-X., Jiang, N., Zhang, H., Wang, S., Pi, Q., Chen, H., He, X., Luo, W. F., Deng, Y., Lu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3907908/v1
The Interplay of Ferroptosis and Cuproptosis in Cancer: Mechanisms and Therapeutic Implications
Wang, J., Chan, L. K. Y., Zhang, T., Li, J., Liu, J., Lau, T., & Wang, C. C. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_233
Tokhtueva, M. D., & Melekhin, V. V. (2024) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2024-04-03
Grey Frequency-Based Methodology for Assessing HeLa Cell DamagePreprint
Li, A., Zhao, L., Liu, C., Xu, X., & Jia, J. (2024) · Research Square · doi:10.21203/rs.3.rs-5250802/v1
Regulating ferroptosis: Toward precision treatment of dysregulated cell death
Landis, H. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-98808-7.00018-7
Invited Commentary: What Is the Link Between Ferroptosis and Cardiac Hypertrophy?
Sun, Q., & Lopaschuk, G. D. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.11.028
NOLC1 Suppresses Immuno-chemotherapy by Inhibiting p53-mediated Ferroptosis in Gastric CancerPreprint
Zhao, S., Lin, J., Zhu, B., Jin, Y., Dong, Q., Ruan, X., Jin, D., Yi, Y., Bai, B., Li, H., et al. (2024) · eLife · doi:10.7554/elife.103904.1
NUBP2 deficiency disrupts the centrosome-check point in the brain and causes primary microcephalyPreprint
Rushforth, R., Shamseldin, H. E., Costantino, N., Michaels, J.-R., Sawyer, S. L., Osmond, M., Kurdi, W., Abdulwahab, F., DiStasio, A., Boycott, K. M., et al. (2025) · medRxiv · doi:10.1101/2025.01.16.25320041
Zhang, R., Zhang, Y., Xue, J., Zhang, R., Xie, J., Luo, X., Yang, X., Wang, H., Liu, J., Wei, J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5116771
Cell Death Mechanisms, Associated Toxicity and Therapeutic Applications
Davila, J. C., Kovalova, N., & Radi, Z. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00265-5
MND1 Promotes the Proliferation of Prostate Cancer Cell Via the CCNB1/p53 Signaling Pathway
Zhao, Z., Zou, Y., Lv, Q., Wu, C., Tang, K., Dai, F., Feng, J., Lai, H., Lai, W., & Qiu, X. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096391591250506064859
NOLC1 Suppresses Immuno-chemotherapy by Inhibiting p53-mediated Ferroptosis in Gastric CancerPreprint
Zhao, S., Lin, J., Zhu, B., Jin, Y., Dong, Q., Ruan, X., Jin, D., Yi, Y., Bai, B., Li, H., et al. (2025) · eLife · doi:10.7554/elife.103904.2
Liang, H., Huang, F.-Y., Xie, W.-J., Chen, M., Wu, R.-H., Dai, S.-Z., Xu, W.-T., Zheng, W.-P., & Tan, G. (2025) · Discover Oncology · doi:10.1007/s12672-025-02687-w
The Effective Stress Response Role of p53 in Inducing Ferroptotic Cell Death
Munshi, C., Mondal, S., Pal, I., Jamil, F., Das, U., & Iyer, M. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010651
ESRP1 exerts anti-tumor role by promoting ferroptosis in diffuse-type gastric cancer
Xu, K., Chen, H., Zhu, X., Han, L., Liu, X., Sang, Y., Wang, X., Cui, X., Cai, B., Shang, L., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03435-2
Zhang, X., Pu, Z., Ran, C., Zhang, X., Guo, C., Deng, Y., Liu, J., Chen, Y., Feng, J., & Liu, S. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1624817
Iyer, S., & Schlichtholz, B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168024 · Cited by 1
TP53 Expression Status Alters Hemoglobinization and Ferroptosis Sensitivity in K-562 Cells
Cardona, C. J., Young, M., & Montgomery, M. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178359
Deng, Z., Xu, J., & Liu, Z. (2025) · Molecular Biotechnology · doi:10.1007/s12033-025-01511-8
Babayeva, G. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24836-8.00004-3
Hua, C., Jiang, S., Li, Y., Qian, J., & Shen, Z. (2025) · Molecular & Cellular Toxicology · doi:10.1007/s13273-025-00573-8
高, 佳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15113124
Sun, Y., Ainiwaer, M., Xiao, B., Hong, Y., Li, N., & Ji, Y. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-07051-w
Wang, X., Zhang, H., Zhang, M., Zhang, X., Mao, W., & Gao, M. (2023) · Figshare · doi:10.6084/m9.figshare.22790443
Zhang, Y., Huang, Z., Li, K., Xie, G., Feng, Y., Wang, Z., Li, N., Liu, R., Ding, Y., Wang, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24979516
He, C., Wang, C., Liu, H., & Baoen, S. (2022) · Figshare · doi:10.6084/m9.figshare.20218311
He, C., Wang, C., Liu, H., & Baoen, S. (2022) · Figshare · doi:10.6084/m9.figshare.20218308
Huang, F., Zhu, M., Wang, H., Du, Z., Wu, Q., He, Y., Liang, Y., Hu, W., & Xie, L. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47121066
Sharma, A., Pathangey, L. B., Chirackal, S. S., Shim, K. G., Fonseca, R., & Swaminathan, S. (2025) · European Journal Of Haematology · doi:10.1111/ejh.70084
Li, S., Zhang, B.-W., Wei, Z.-J., Xi, Y., Zhang, G.-A., Zhang, Y., Kou, D.-C., Song, X.-P., Huang, J., Song, P., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05983-4
Self-citationAbhimanyu, A., Lefebvre, F., Nemes, E., Jablonski, N. G., Wilkinson, R. J., & Coussens, A. K. (2025) · medRxiv · doi:10.64898/2025.12.22.25342836
ACE/ACE2 Steady State: A Novel Mechanism of Rosmarinic Acid in Alcohol-Associated Gastric Ulcer
Luo, T.-F., Zhang, X., Zheng, Z.-Q. N., Zeng, T., Li, F. Y., Wan, L.-H. N., Yi, Z., & Zhu, L. (2025) · International Journal of Pharmacology · doi:10.31083/ijp47086
Singh, P., & Rath, S. L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411331
Liu, Y.-F., He, T.-F., Zhao, Z., Wu, B.-S., Liang, Y., Li, L.-M., Chen, J., & Yu, Y.-P. (2026) · Marine Life Science & Technology · doi:10.1007/s42995-025-00346-1
Self-citationChen, H., Kong, Y., & Dong, Q. (2026) · Discover Oncology · doi:10.1007/s12672-025-04320-2
Иванович, В. В., Sorokoletova, E. F., & Shabanov, P. D. (2026) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf691330
Wei, L., Liu, T., Ma, Y., Li, J., & Qian, H. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101156
Guo, P., Liu, Q., Li, J., Li, S., Ding, W., Zhao, Q., Zhou, S., Meng, F., Tang, Z., & Li, W. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05523-7
Rakotopare, J. (2024) · theses.fr (ABES) · doi:10.70675/cc79cc10zbaf8z4e88za003z8a8d37707576
Metadata
- Authors
- Liu, Y., & Gu, W.
- Affiliations
- Herbert Irving Comprehensive Cancer Center (US)
- Corresponding author
- Gu, Wei
- ORCID
- Venue
- Cell Death & Differentiation
- Published
- 2022-01-27
- Volume
- 29
- Issue
- 5
- Pages
- 895-910
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC9091200
- OpenAlex
- W4210576858
- Cited by
- 540
- References
- 141
- Citations by year
- 2026: 88 · 2025: 153 · 2024: 128 · 2023: 110 · 2022: 60
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253059, R01CA254970)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, ferroptosis, tumor suppression, GPX4, iron metabolism, reactive oxygen species, non-apoptotic cell death, cancer therapy
- MeSH terms
- Ferroptosis, Humans, Neoplasms, Tumor Suppressor Protein p53, Apoptosis, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review